Showing results (71-80 of 139) with videos related to
Sort By:
Pageof 14
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 20, 2007
D2 receptor occupancy of olanzapine pamoate depot using positron emission tomography: an open-label study in patients with schizophreniaDavid Mamo, Shitij Kapur, Matcheri Keshavan, et al.Journal of Medicinal Chemistry|August 5, 2005
A positron emission tomography radioligand for the in vivo labeling of metabotropic glutamate 1 receptor: (3-ethyl-2-[11C]methyl-6-quinolinyl)(cis- 4-methoxycyclohexyl)methanoneYiyun Huang, Raj Narendran, François Bischoff, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2009
Human biodistribution and dosimetry of the D2/3 agonist 11C-N-propylnorapomorphine (11C-NPA) determined from PETCharles M Laymon, N Scott Mason, W Gordon Frankle, et al.The Journal of Pharmacology and Experimental Therapeutics|November 12, 2003
Pharmacological and genetic characterization of two selective serotonin transporter ligands: 2-[2-(dimethylaminomethylphenylthio)]-5-fluoromethylphenylamine (AFM) and 3-amino-4-[2-(dimethylaminomethyl-phenylthio)]benzonitrile (DASB)Qian Li, Li Ma, Robert B Innis, et al.Neuroimage|February 24, 2009
Within-subject comparison of striatal D2 receptor occupancy measurements using [123I]IBZM SPECT and [11C]Raclopride PETAna M Catafau, Marina Suarez, Santiago Bullich, et al.Nuclear Medicine and Biology|March 8, 2003
Evaluation of [3H]LY341495 for labeling group II metabotropic glutamate receptors in vivoRikki N Waterhouse, Mark E Schmidt, Abida Sultana, et al.Nuclear Medicine and Biology|October 17, 2002
Synthesis and pharmacological characterization of a new PET ligand for the serotonin transporter: [11C]5-bromo-2-[2-(dimethylaminomethylphenylsulfanyl)]phenylamine ([11C]DAPA)Yiyun Huang, Dah-Ren Hwang, Zhihong Zhu, et al.Synapse (New York, N.Y.)|August 29, 2012
Synthesis and characterization of two PET radioligands for the metabotropic glutamate 1 (mGlu1) receptorYiyun Huang, Rajesh Narendran, Francois Bischoff, et al.Depression and Anxiety|January 26, 2007
Striatal dopamine D(2) receptor availability in OCD with and without comorbid social anxiety disorder: preliminary findingsFranklin R Schneier, Diana Martinez, Anissa Abi-Dargham, et al.The Journal of Pharmacology and Experimental Therapeutics|January 28, 2010
A comparative evaluation of the dopamine D(2/3) agonist radiotracer [11C](-)-N-propyl-norapomorphine and antagonist [11C]raclopride to measure amphetamine-induced dopamine release in the human striatumRajesh Narendran, N Scott Mason, Charles M Laymon, et al.Pageof 14